Chabiotech Co

Chabiotech Co EBIT per Share

The EBIT per Share of Chabiotech Co (085660.KQ) as of Nov 1, 2026 is -521.06 KRW. In the previous year, EBIT per Share was 332.65 KRW — a change of -256.64% (lower).

EBIT per Share

-521.06KRW

YoY

-256.64%

Last updated:

EBIT per Share of Chabiotech Co is 2025 -521.06 KRW. EBIT per Share of Chabiotech Co was 2024 332.65 KRW. It decreases by -256.64% lower compared to the previous year.

The Chabiotech Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
347.45 KRW
Jan 1, 2019
82.88 KRW
Jan 1, 2020
-113.69 KRW
Jan 1, 2021
131.95 KRW
Jan 1, 2022
-1,053.55 KRW
Jan 1, 2023
-135.34 KRW
Jan 1, 2024
332.65 KRW
Jan 1, 2025
-521.06 KRW
The Chabiotech Co EBIT per Share history
YEAREBIT per ShareYoY
-521.06KRW-256.64%
332.65KRW-345.79%
-135.34KRW-87.15%
-1,053.55KRW-898.46%
131.95KRW-216.06%
-113.69KRW-237.17%
82.88KRW-76.15%
347.45KRW-360.12%
-133.57KRW-118.21%
733.44KRW-138.27%
-1,916.44KRW-173.40%
2,610.89KRW-75.71%
10,750.75KRW+18.78%
9,050.76KRW+161.64%
3,459.23KRW+59.09%
2,174.39KRW+42.65%
1,524.29KRW+105.03%
743.45KRW+7.79%
689.74KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Chabiotech Co Stock analysis

What does Chabiotech Co do? Cha Biotech Co., Ltd. generates revenue through its bio segment, which provides medical services, develops stem cell and cell therapy products, produces cosmetics and cosmetic raw materials, distributes medical devices, and offers cord blood storage and health care services. The optical segment manufactures optical lenses, optical modules, and other parts for mobile phone cameras. The company serves healthcare providers, medical device distributors, and consumers seeking cosmetic and health services. Its bio segment targets medical and wellness markets, while the optical segment caters to mobile phone manufacturers and component suppliers. The company's products include stem cell therapy solutions, cosmetic raw materials, medical devices, and optical components. It operates through two main segments: bio and optical, with the bio segment focusing on healthcare and wellness services, and the optical segment on manufacturing optical parts for mobile devices. The bio segment's cord blood storage services are a key offering for health-conscious consumers, while the optical segment supplies components to mobile phone camera manufacturers. Cha Biotech's revenue streams come from medical service provision, product development in cell therapy, cosmetic production, medical device distribution, cord blood storage, and optical component manufacturing. The company serves healthcare institutions, cosmetic brands, medical device companies, and mobile phone manufacturers. Its bio segment's health care services and optical segment's mobile phone camera parts are central to its business model. Chabiotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Chabiotech Co stock

EBIT per Share of Chabiotech Co is -521.06 KRW in 2025.

EBIT per Share of Chabiotech Co changed from 332.65 KRW to -521.06 KRW, representing a -256.64% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Chabiotech Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Chabiotech Co

All Key Metrics — Chabiotech Co